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Abstract Objective To examine the efﬁcacy of structured
early consultation among employees at high risk for future
long-term sickness absence, in the prevention and/or
reduction of sickness absence. The focus of the experiment
was the timing of the intervention, that is, treatment before
sickness absence actually occurs. Methods In the current
prospective randomized controlled trial (RCT), employees
at high risk for long-term sickness absence were selected
based on responses to a 34-item screening questionnaire
including demographic, workplace, health and psychoso-
cial factors associated with long-term sickness absence
([28 days). A total of 299 subjects at risk for future long-
term sickness absence were randomized in an experimental
group (n = 147) or in a control group (n = 152). Subjects
in the experimental group received a structured early
consult with their occupational physician (OP), in some
cases followed by targeted intervention. The control group
received care as usual. Sickness absence was assessed
objectively through record linkage with the company reg-
isters on sickness absence over a 1 year follow-up period.
Results Modiﬁed intention-to-treat analysis revealed sub-
stantial and statistically signiﬁcant differences (p = 0.007)
in total sickness absence duration over 1 year follow-up
between the experimental (mean 18.98; SD 29.50) and
control group (mean 31.13; SD 55.47). Per-protocol anal-
ysis additionally showed that the proportion of long-term
sickness absence spells ([28 days) over 1 year follow-up
was signiﬁcantly (p = 0.048) lower in the experimental
(9.1%) versus control group (18.3%). Conclusions Struc-
tured early consultation with the OP among employees at
high risk for future long-term sickness absence is suc-
cessful in reducing total sickness absence.
Keywords Epidemiology  Occupational health
intervention  Prevention  Sick leave
Introduction
Long-term sickness absence and work disability constitute
considerable public health problems, with important
consequences for individuals, their families, for work-
places, and for society [1]. Within the Western countries
musculoskeletal complaints and psychological health
complaints are highly prevalent [2, 3], and account for the
majority of certiﬁed sick leave [4–11]. Both musculo-
skeletal and mental health complaints are associated with
prolonged sickness absence spells and permanent work
disability. In the Netherlands, musculoskeletal and mental
health complaints accounted for 65.5% of permanent
work disability in 2004 [12]. Stansfeld et al. [7] for
example demonstrated the importance of psychiatric
disorders as a cause of sickness absence in the Whitehall
II study, where psychiatric disorders were the third most
common cause of certiﬁed absences of 8–21 days in
duration and the second most common certiﬁed cause of
absence of over 21 days for women working in the public
service sector.
Longer absences are associated with a reduced proba-
bility of returning to work [13–16]. Nieuwenhuijsen et al.
[17] demonstrated in a cohort of Dutch employees on sick
leave with common mental disorders that the diagnoses of
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of a longer time until occupational rehabilitation. Possible
explanations for the difﬁculty in returning to work are the
illness severity in this stage, and the fact that the disorder
may be intertwined with the work situation, since work
characteristics may have been partially causing the mental
health problems [18]. Some studies show that the effec-
tiveness of treatment and rehabilitation of employees on
sick leave due to mental health problems is often limited
[19–21]. Therefore, it is hypothesized that a preventive
strategy aimed at early intervention of employees before
sickness absence or disability occurs, may be more effec-
tive. Several preventive strategies may be considered. One
strategy could consist of primary prevention, implying that
for all employees exposure to risk factors of sickness
absence is limited as much as possible. Although this
approach is the basis of many occupational health legisla-
tion and guidelines, this approach is not feasible in many
cases. A second strategy would be to select employees at
high risk for health complaints based on symptom levels,
for example with respect to levels of fatigue, and provide
treatment speciﬁcally aimed at inﬂuencing these symptoms
and assuming that sickness absence will then be positively
inﬂuenced as well. Although such strategy would probably
be effective in reducing complaints, this does not neces-
sarily imply a reduction of sick leave. A third and more
promising strategy, applied in the present study, would be
to speciﬁcally select those employees with a high risk of
future long-term sickness absence, where an intervention
should be aimed at the diffuse and complex range of risk
factors in the etiology of sickness absence. For employees
selected according to this strategy, the basis of intervention
is the timing of the intervention that is, treatment before
sickness absence actually occurs. A prerequisite for this
preventive strategy however, is the ability to identify
employees with a high risk for disability before sickness
absenteeism actually occurs. For this purpose a screening
questionnaire, the so-called Balansmeter, was developed
[IJ. Kant et al., unpublished data] based on data of the
Maastricht Cohort Study [22]. Internal validation in the
Maastricht Cohort Study and external validation in a pro-
spective cohort of bank employees in the Netherlands
revealed good predictive properties for future long-term
sickness absence, or disability [IJ. Kant et al., unpublished
data]. As such, the Balansmeter may constitute a sound
basis for screening and the application of a preventive
approach, in which employees at high risk for future
sickness absence can be detected and offered early con-
sultation to prevent or reduce future sickness absence and
subsequent disability. The aim of this study was to examine
the efﬁcacy of structured early consultation among
employees at high risk for future long-term sickness
absence, as identiﬁed by the Balansmeter, in the prevention
or reduction of sickness absence over a 1 year follow-up
period by means of a RCT.
Methods
Design
A randomized controlled trial (RCT) was conducted in the
occupational health setting. Employees at high risk for
long-term sickness absence, as identiﬁed by the Balans-
meter, were randomized to receive structured early
consultation with the occupational physician (OP) or to be
followed up in a control group. Randomization sequences
were generated by an independent research assistant using
computerized random number generators. Block randomi-
zation (block size 2) was used to ensure equal numbers in
each group and smooth enrollment in the trial over time.
The primary outcome concerns sickness absence, which
was measured objectively over a 12-month follow-up
period between two through 14 months after completion of
the Balansmeter. This study complied with the Declaration
of Helsinki. Informed written consent was obtained from
all participants in the trial. The complete study was intro-
duced by the occupational health service from the
participating company. The OPs from this occupational
health service carried out the consultation, through which
the whole study is covered by the medical guidelines of the
occupational health service, thereby ensuring all subjects’
privacy.
Procedure
This study was conducted in a large banking company in
the Netherlands. The total population of this company was
in 2003 characterized by a mean sickness absence of 5.0%
(4.0% in men and 5.6% in women). In 2003, a random
selection of 9,863 of 28,000 employees of this company
received the screening questionnaire, the so-called Ba-
lansmeter [IJ. Kant et al., unpublished data], at their home
address. In the invitation letter, employees were asked to
provide written informed consent, which covered the usage
of the questionnaire data, company data on sickness
absence, and the possibility to be part of the trial. After
2 weeks a reminder was sent to all non-respondents.
Recruitment started in January 2003 and was completed in
October 2003. In total, 4,950 employees (50.2%) respon-
ded to the questionnaire.
The Balansmeter, speciﬁcally developed for employees
with an ofﬁce work environment, was used to identify the
employees at high risk for future long-term sickness
absence. The Balansmeter was developed and validated in
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123the Maastricht Cohort Study [22], and captures 19 indi-
vidual predictors for men and 22 for women. Due to
overlapping in predictors between men and women, the
Balansmeter captures 34 multiple-choice questions origi-
nating from domains of the work environment, e.g.,
working conditions, psychological job demands; charac-
teristics of the private situation, e.g., having to care for a
chronically ill family member, the occurrence of life-
events in the past year; (mental) health status, e.g.,
depressed mood; demographic factors, such as age and
gender, and sickness absence history. Using an algorithm
based on the weighted factors of the individual items of the
model, a total score can be calculated, with higher scores
indicating a higher risk for future long-term sickness
absence [IJ. Kant et al., unpublished data]. A cut-off point
has been deﬁned, giving priority to a high speciﬁcity. For
men, this resulted in a speciﬁcity of the Balansmeter of
94.4% and a sensitivity of 49.4% to detect future long-term
sick leave ([28 days) during the next year. This corre-
sponds with a Relative Risk (RR) for long-term sickness
absence of 13.39 (95% CI 8.89–20.15). For women the
speciﬁcity was 94.7% with a sensitivity of 30.3%, resulting
in a RR for long-term sickness absence of 5.79 (95% CI
3.75–8.94). Subjects were not only selected because of
their current health status, although it is observed that
subjects with a chronic condition are more prone to be
selected by the Balansmeter.
For this RCT, employees were eligible if they scored
above the predeﬁned cut-off point of the Balansmeter, were
not absent from work, not pregnant and not receiving
treatment by the OP at the time of completing the
Balansmeter. A total of 299 respondents fulﬁlled these
criteria. Due to a data processing error, initially 327
respondents were randomized, including 28 respondents
who were incorrectly classiﬁed as scoring above the cut-off
point of the Balansmeter. These persons were excluded
from the trial and explain the different numbers of
employees allocated to the experimental and control group.
For the intention-to-treat analysis we had to exclude
subjects on baseline criteria that became only apparent
after randomization, that is, after randomization we had to
exclude those absent from work at the start of follow-up on
sickness absence (2 months after receiving Balansmeter),
since early consultation targets at those not on sick leave.
Also excluded were those who left the ABN AMRO orga-
nization at one point during the follow-up period, as no
objective sickness absence data could be obtained for these
subjects. Pregnant women were excluded to avoid counting
absence spells speciﬁcally related to pregnancy leave. Fur-
thermore, one person was excluded because she indicated to
already receive treatment before the start of the trial.
In this study, also a modiﬁed intention-to-treat analysis
was applied in which we additionally excluded those
already receiving treatment by the OP, and those who had
sought external treatment in the time lag between com-
pletion of the screening questionnaire and the consult with
the OP, because for these persons early consultation was no
longer applicable.
For the per-protocol analysis we additionally excluded
those employees in the experimental group who did not
accept the invitation for the consult with the OP. As such,
the per-protocol analysis will reﬂect the group for which it
was succeeded to advance intervention before sickness
absence could occur.
A ﬂow diagram on patient recruitment, allocation and
outcome assessment is presented in Fig. 1.
Intervention
Employees at high risk for long-term sickness absence
were randomized in an experimental group receiving early
consultation or in a control group receiving care as usual.
The focus of the experiment was the timing of the inter-
vention, that is, before sickness absence might actually
occur, rather than the type of intervention. Employees in
the experimental group were invited for an extensive, one
to one and a halve hour, consultation with the OP. The OP
was chosen as the expert for consulting with employees at
high risk for long-term sickness absence, because this
occupational group is speciﬁcally equipped for recognizing
work-related and non-work-related conditions and their
interactions, as well as equipped for realizing targeted
referrals to specialized care. The average number of days
between receipt of the Balansmeter at their home address
and the consult with the OP was 79.01 days (SD 24.53).
Individual Balansmeter results were sent to the OPs in
advance of the actual consult with the employee. Struc-
tured early consultation was conducted according to a
protocol, capturing several steps. The ﬁrst step of the
consult consisted of clariﬁcation of the main symptoms and
complaints. This was done by going through the individual
Balansmeter results and through the conduct of a social and
medical anamnesis as well as an anamnesis of the private
situation and work situation, e.g., job history, job content,
working conditions and terms of employment. Following
problem and symptom clariﬁcation, the next step in the
consultation was to explain the relation between these
symptoms and risk of future long-term sickness absence.
The ﬁnal step of the consult consisted of explaining and
discussing the expectations and beneﬁts of early treatment
for the employee. This consult may then result in a targeted
intervention focusing at the speciﬁc complaints presented
by the employee. Targeted intervention may consist of
various conventional treatments, ranging from additional
sociomedical counseling by the OP to psychotherapy,
J Occup Rehabil (2008) 18:79–86 81
123counseling by a social worker, or specialized and/or
intensiﬁed care for a speciﬁc disease. In the present RCT,
84 employees had a consult with the OP, another 14
received additionally treatment besides the consult with the
OP, as retrieved from questionnaires completed by the OPs.
Participants in the control group were offered no research
intervention. If employees in the control group asked for
help or in case of sickness absence, they received care as
usual from the occupational health service.
In an earlier pilot study by two OPs of the occupational
health service, speciﬁc information about the target popu-
lation, and way of consulting this particular group, was
obtained. In the RCT, a total of 12 OPs participated. They
received a 1-day training in the conduct of structured early
consultationsbeforethestudystarted.Besidesexplainingthe
aimofthestudy,thetrainingfocusedonthedifferentstepsin
the protocol for structured early consultation as described
above. Based on experiences from the pilot study, the
training further speciﬁcally aimed at the attitude needed for
speciﬁcally consulting with employees who present them-
selves with relatively mild complaints and not yet on sick
leave. Therefore, special attention was paid to symptom
clariﬁcation and awareness raising for this target group.
Finally also tools and means for referral to specialized care
following the consult were provided during this training.
Outcome Measurement
All information regarding sickness absence was measured
through record linkage on an individual level with the
company registers on certiﬁed sickness absence. Long-term
sickness absence was deﬁned as a sickness absence spell
lasting for more than 28 consecutive calendar days. This
deﬁnition was chosen because, in the Netherlands, after
Employees addressed 
(n=9863)
Employees responding 
(n=4950)
Employees at risk and 
randomized (n=299)
Allocated to intervention 
group (n=147)
Allocated to control group 
(n=152)
Employees for intention to 
treat analysis (n=131)
Employees for intention to 
treat analysis (n=132)
- No intervention (n=12)
Employees for per protocol 
analysis (n=131)
Employees for per protocol 
analysis (n=99)
Employees not at risk, 
excluded from trial 
(n=4651)
- Already receiving treatment by OP or external
treatment at time of consult with OP (n=14)
- Already receiving treatment by OP and external
treatment at time of consult with OP (n=5)
- Both on sick leave and already receiving 
treatment by OP or external treatment at time
of consult with OP (n=2)
- On sick leave at start follow-up (n=9)
- Left company (n=10)
- Pregnant during follow-up (n=2)
- On sick leave at start follow-up (n=6)
- Left company (n=6)
- Pregnant during follow-up (n=2)
- Already receiving treatment before
consult with OP (n=1)
Employees for modified 
intention to treat analysis 
(n=131)
Employees for modified 
intention to treat analysis  
(n=111)
Fig. 1 Flow diagram of patient recruitment, allocation and outcome assessment
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12328 days of sickness absence the employer is obliged to have
completed a plan for reintegration and to report these
employees to the sick leave insurance company. In line with
the development of the Balansmeter, predicting sickness
absence starting 2 months after completion of the ques-
tionnaire, the follow-up on sickness absence captured a
12-monthfollow-up period between two through 14 months
after completion of the Balansmeter. Apart from the sick-
ness absence data based on the company records, employees
were asked in the Balansmeter to indicate whether they
were absent at the time of completing the questionnaire.
This information was used to exclude the employees absent
from work at the time of completing the questionnaire.
Statistical Analysis
Based on the experiences within the Maastricht Cohort
Study [22], we expected the incidence of long-term sickness
absence of those scoring above the cutoff point of the
Balansmeter to be 50% over a 1 year follow-up period. To
reduce this rate from 50 to 35% (implying a 30% decrease),
a power calculation before the study indicated that we
would need 145 participants in both groups with a power of
0.9 and an alpha of 0.05. Data were analyzed on an inten-
tion-to-treat, modiﬁed intention-to-treat and per-protocol
basis. Poisson regression analyses were used to test differ-
ences in sickness absence duration and sickness absence
frequency. Other statistical procedures included Chi-square
tests. All analyses were performed using SPSS and SAS.
Results
Baseline characteristics of all participants in the trial are
displayed in Table 1. Age, mean number of years working
for the company, and working hours per week were com-
parable in both groups. Small differences between the
groups exist with respect to gender, educational level, and
prevalence of conﬂicts with supervisor, depressed mood,
the presence of a long-term illness, and the occurrence of
life-events in the past year.
Table 2 shows differences in sickness absence over a
1 year follow-up period between the experimental and
control group when analyzed according to the intention-to-
treat and modiﬁed intention-to-treat principle. When ana-
lyzed according to the intention-to-treat principle,
participants in the experimental group showed a lower total
sickness absence duration, lower sickness absence fre-
quency, and lower proportion of long-term sickness
absence spells as compared with the control group.
Although relevant differences were observed, these
differences were not statistically signiﬁcant. The intention-
to-treat analysis in the present study provides a more
conservative estimate of the effectiveness of early consul-
tation by including participants who were randomized for
consultation but did not fulﬁll the criteria for early inter-
vention. The modiﬁed intention to treat analysis, in
contrast, revealed substantial and statistically signiﬁcant
differences in total sickness absence duration between the
experimental and control group over 1 year follow-up.
Table 3 shows differences in sickness absence over a
1 year follow-up period between the experimental and
control group when analyzed according to the per-protocol
principle. As shown in Table 3, substantially and statisti-
cally signiﬁcant differences were observed with respect to
sickness absence duration and the proportion of long-term
sickness absence spells between the experimental and
control group, with an almost twofold higher number of
total number of sickness absence days over 12 months
follow-up in the control group versus the experimental
group. These analyses were also stratiﬁed for gender. In
Table 1 Baseline
characteristics of the study
participants
Experimental
group (n = 132)
Control
group (n = 131)
Gender, % male 73.5 68.7
Age, mean (SD) 46.32 (8.40) 46.58 (8.28)
Educational level
Low 40.5 49.6
Medium 48.1 34.9
High 11.5 15.5
Years working for company, mean (SD) 23.87 (10.96) 23.54 (11.13)
Working hours/week, mean (SD) 34.37 (3.95) 33.90 (4.77)
Conﬂicts with supervisor (%) 5.3 8.6
Depressed mood (%) 17.6 20.6
Long-term illness (%) 54.5 47.5
Life-events in the past year (%) 58.3 61.5
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123men, substantial differences were observed between the
experimental versus control group with respect to total
sickness absence duration [mean 18.12 (SD 30.91) versus
mean 26.38 (SD 42.74); p = 0.090], although these results
just failed to reach statistical signiﬁcance. In women,
substantially and statistically signiﬁcant differences were
observed with respect to sickness absence duration with an
almost threefold higher number of total number of sickness
absence days over 12 months follow-up in the control
group versus the experimental group [mean 41.56 (SD
75.98) versus mean 15.23 (SD 19.28); p = 0.021].
The per-protocol analyses for total sickness absence
duration were also stratiﬁed for educational level. Non-
signiﬁcant differences in sickness absence duration were
observed between the experimental and control group in the
groups of employees with a low educational level [mean
14.98(SD23.54)versusmean23.80(SD37.53);p = 0.106]
or a high educational level [mean 9.14 (SD 13.02) versus
mean 13.35 (SD 16.67); p = 0.506]. Regarding employees
with a medium educational level substantial and statistically
signiﬁcantdifferenceswerefoundbetweentheexperimental
and control group [mean 20.72 (SD 33.08) versus mean
50.22 (SD 79.61); p = 0.003].
Discussion
The aim of this study was to evaluate the efﬁcacy of early
consultation in an occupational health setting for employ-
ees at high risk for future prolonged sickness absence in a
RCT. To our knowledge, this is the ﬁrst study examining
the timing of intervention in relation to future long-term
sickness absence. The RCT revealed substantial differences
between the experimental and control group with respect to
total sickness absence duration in favor of the experimental
group. Stratiﬁed analyses for gender and educational level
were also conducted, since they are often reported to be
associated with sickness absence [23, 24]. In general,
sickness absence duration was highest among women and
among those with medium educational level. However,
also the reduction in sickness absence was highest in the
experimental group of these strata.
Screening employees at risk for future long-term sick-
ness absence was done by means of the Balansmeter. The
Balansmeter is capable of identifying the workers at risk,
since in this study population the risk for long-term sick-
ness absence was signiﬁcantly higher for the selected
employees as compared to the non-selected employees.
For men the Relative Risk for long-term sickness absence
was 3.90 (95% CI 2.35–6.45) and for women 2.62 (95% CI
1.44–4.77) [IJ. Kant et al., unpublished data]. It should be
noted that this is especially remarkable given the fact that
the sickness absence percentage in the total company was
rather low at the time of study, which is in general nega-
tively associated with the positive predictive value of a
screening instrument. It should be noted however, that due
to the response rate of 50% many employees at risk could
not be identiﬁed.
Relevant differences in sickness absence duration were
already observed in the intention-to-treat analysis, and
Table 3 Differences in sickness absence (calendar days) over 12 months follow-up between experimental and control group according to per-
protocol analysis
Experimental group (n = 99) Control group (n = 131) p-value
Total sickness absence duration (SD) 17.36 (28.25) 31.13 (55.47) 0.003
Sickness absence frequency (SD) 2.17 (1.90) 2.60 (3.06) 0.178
% Long-term sickness absence ([28 days) 9.1 18.3 0.048
Table 2 Differences in sickness absence (calendar days) over 12 months follow-up between experimental and control group according to
intention-to-treat analysis and modiﬁed intention-to-treat analysis
Intention-to-treat analysis Experimental group (n = 132) Control group (n = 131) p-value
Total sickness absence duration (SD) 25.97 (44.84) 31.13 (55.47) 0.290
Sickness absence frequency (SD) 2.40 (2.04) 2.60 (3.06) 0.500
% Long-term sickness absence ([28 days) 13.6 18.3 0.300
Modiﬁed intention-to-treat analysis Experimental group (n = 111) Control group (n = 131) p-value
Total sickness absence duration (SD) 18.98 (29.50) 31.13 (55.47) 0.007
Sickness absence frequency (SD) 2.25 (1.91) 2.60 (3.06) 0.256
% Long-term sickness absence ([28 days) 10.8 18.3 0.102
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123were about as high as we expected from the power calcu-
lation. However, these differences failed to reach statistical
signiﬁcance. This can be attributed to the lower incidence
of sickness absence in this study population as compared to
the population which was used for the development of the
Balansmeter. The power calculation of this study was
based on the latter incidence. Although the incidence of
sickness absence in the current study was much lower than
expected, the modiﬁed intention-to-treat and per protocol
analyses revealed that sickness absence was substantially
and signiﬁcantly lower in the experimental group as com-
pared to the control group.
Considerable differences in the efﬁcacy of structured
early consultation in reducing long-term sickness absence
were observed when comparing the results of the intention-
to-treat versus modiﬁed intention-to-treat and per-protocol
analyses. Quite a few subjects in the experimental group
had already sought treatment before the consult with the
OP. These subjects were excluded from the modiﬁed
intention-to-treat and per-protocol analyses because adding
early intervention to an already ongoing treatment would
probably have no surplus value, and in that case the
expression early consultation would be no longer applica-
ble. This exclusion criterion may have resulted in an
overestimation of the results from the modiﬁed intention-
to-treat and per-protocol analyses, if these employees
would be characterized by a higher level of complaints. On
the other hand, when employees in the control group also
have sought treatment, resulting in beneﬁcial effects, then
the results of the modiﬁed intention-to-treat and per-pro-
tocol analysis may be underestimated again. This point
further stresses that early consultation is only effective
among those who have not sought treatment themselves yet
and emphasize the need of a short(er) time lag between
screening and consultation with the OP. In this RCT the
time lag between completion of the Balansmeter and the
consult with the OP was on average 79 days, of which the
dispatch of questionnaires, monitoring response, reminders,
checking informed consent, and subsequent data process-
ing and randomization took about 42 days. In order to
reduce the time lag between completion and the actual
consult, an electronic web based version of the screening
questionnaire is under development. This application may
reduce the time lag by more than 50%. Further research
should indicate how this time lag can be further reduced.
It should be noted that in this study the per-protocol
deﬁnition is relatively mild, implying that employees at
least had a consult with the OP. Further research should
investigate the optimal intervention for this population,
where existing treatments may be adjusted to the mild level
of complaints and/or ﬁne-tuning of treatments with regard
to different target populations, for example focusing on
musculoskeletal or mental health complaints, or educa-
tional level.
Especially in early consultation, at the beginning of a
help-seeking process of the employee, we expect the role
of the physician in both the guidance towards treatment and
treatment itself to be very large. Therefore, differences in
treatment effect between the different OPs cannot be ruled
out. Given the numbers of employees and OPs in this RCT,
subgroup analyses to explore these potential differences
could not be conducted however. This subject is an
important source for improvement and further study.
A cost-beneﬁt evaluation was not part of this study.
However, based on the intention to treat analysis we cal-
culated that the decrease in sickness absence days in this
study was 681 days. Using the average labor cost in the
study population of € 189 per worker per calendar day, the
proﬁts of reduction of sickness absence in this study
amounted to € 127,368. As this study is an RCT, this
amount saved can be attributed to 50% of the screened
population. It remains important, however, to monitor the
proﬁts of reduction of sickness absence versus the costs in
terms of for instance monitoring, screening and treatment
costs, of which the treatment costs will capture the majority
of expenditure. Also with regard to cost-beneﬁt evalua-
tions, it might be beneﬁcial to adjust consultations to the
relatively mild stage of complaints among employees at
risk for sickness absence, and/or to focus on more speciﬁc
target groups.
Efﬁcacy of structured early consultation was evaluated
among employees with an ofﬁce work environment.
Therefore, this study is not fully representative for the
general working population, limiting the external validity
of our ﬁndings. Still, we would argue that the disadvan-
tages concerning the ability to generalize our ﬁndings do
not outweigh the advantages of this study population and
intervention. That is, the RCT was developed for use in the
occupational health care setting, characterized by a case
load of stress-related (mental) disorders, in contrast with
specialized care, where patients present with more clearly
deﬁned disorders. At this time, separate Balansmeter
modules are being developed for use in other work envi-
ronments, including industry and health care, enabling the
evaluation of structured early consultations in other
settings.
In conclusion, while future studies should explore sev-
eral aspects for further improvement, regarding more
speciﬁc target groups, adjusted treatments and a swift start
of early treatment after screening, the results of this study
clearly indicate that structured early consultation with the
OP, aiming at employees with a high risk for future long-
term sickness absence, appears to be a promising strategy
for preventing and/or reducing sickness absence.
J Occup Rehabil (2008) 18:79–86 85
123Acknowledgments This study was ﬁnancially supported by the
Care and Public Health Research Institute (CAPHRI), Maastricht,
the Netherlands, and ABN AMRO Arbo Services, Amsterdam,
the Netherlands. The authors acknowledge the contribution of
Dr. G. M. H. Swaen, Maastricht University, in the initiation of this
RCT, Dr. U. Bu ¨ltmann, currently employed at the University
Medical Center Groningen, for her contribution in the ﬁrst phase of
this study, including data collection, and Mr. J. J. M. Slangen,
Maastricht University, for data management.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Marmot M, Feeney A, Shipley M, North F, Syme SL. Sickness
absence as a measure of health status and functioning: from the
UK Whitehall II study. J Epidemiol Commun H 1995;49:124–30.
2. Paoli P, Merllie ´ D. Third European survey on working condi-
tions. Dublin: European foundation for the improvement of living
and working conditions 2001.
3. Ihlebaek C, Eriksen HR, Ursin H. Prevalence of subjective health
complaints (SHC) in Norway. Scand J Pub Health 2002;30:20–9.
4. Tellnes G, Svendsen KO, Bruusgaard D, Bjerkedal T. Incidence
of sickness certiﬁcation. Proposal for use as a health status
indicator. Scand J Prim Health Care 1989;7:111–7.
5. Nystuen P, Hagen KB, Herrin J. Mental health problems as a
cause of long-term sick leave in the Norwegian workforce. Scand
J Pub Health 2001;29:175–85.
6. Houtman ILD, Smulders PGW, Klein Hesselink DJ. Trends in
arbeid 2002 [Trends in work]. Hoofddorp: TNO Arbeid 2002.
7. Stansfeld S, Feeney A, Head J, Canner R, North F, Marmot M.
Sickness absence for psychiatric illness: the Whitehall II study.
Soc Sci Med 1995;40:189–97.
8. Hensing G, Spak F, Alexanderson K, Allebeck P. Sick leave
among women and the role of psychiatric disorder. Scand J Soc
Med 1997;25:185–92.
9. Hemingway H, Shipley MJ, Stansfeld S, Marmot M. Sickness
absence from back pain, psychosocial work characteristics and
employment grade among ofﬁce workers. Scand J Work Environ
Health 1997;23:121–9.
10. Alexanderson KA, Borg KE, Hensing GK. Sickness absence with
low-back, shoulder, or neck diagnoses: an 11-year follow-up
regarding gender differences in sickness absence and disability
pension. Work 2005;25:115–24.
11. Hensing G, Andersson L, Brage S. Increase in sickness absence
with psychiatric diagnosis in Norway: a general population-based
epidemiologic study of age, gender and regional distribution.
BMC Med 2006;4:19.
12. Central Bureau of Statistics. Statistisch Jaarboek 2005 [statistical
yearbook 2005]. Voorburg/Heerlen: Centraal Bureau voor de
Statistiek 2005.
13. Henderson M, Glozier N, Holland Elliott K. Long term sickness
absence. BMJ 2005;330:802–3.
14. Frank JW, Kerr MS, Brooker AS, DeMaio SE, Maetzel A,
Shannon HS, Sullivan TJ, Norman RW, Wells RP. Disability
resulting from occupational low back pain. Part I: What do we
know about primary prevention? Spine 1996;21:2908–17.
15. Williams DA, Feuerstein M, Durbin D, Pezzullo J. Health care
and indemnity costs across the natural history of disability in
occupational low back pain. Spine 1998;23:2329–36.
16. Watson PJ, Main CJ, Waddell G, Gales TF, Purcell-Jones G.
Medically certiﬁed work loss, recurrence and costs of wage
compensation for back pain: a follow-up study of the working
population of Jersey. Br J Rheumatol 1998;37:82–6.
17. Nieuwenhuijsen K, Verbeek JH, de Boer AG, Blonk RW, van
Dijk FJ. Predicting the duration of sickness absence for patients
with common mental disorders in occupational health care. Scand
J Work Environ Health 2006;32:67–74.
18. Janssen N, van den Heuvel WP, Beurskens AJ, Nijhuis FJ,
Schroer CA, van Eijk JT. The Demand-Control-Support model as
a predictor of return to work. Int J Rehabil Res 2003;26:1–9.
19. Van der Klink JJ, Blonk RW, Schene AH, Van Dijk FJ. Reducing
long term sickness absence by an activating intervention in
adjustment disorders: a cluster randomised controlled design.
Occup Environ Med 2003;60:429–37.
20. Huibers MJ, Beurskens AJ, Van Schayck CP, Bazelmans E,
Metsemakers JF, Knottnerus JA, Bleijenberg G. Efﬁcacy of
cognitive-behavioural therapy by general practitioners for unex-
plained fatigue among employees: Randomised controlled trial.
Br J Psychiatry 2004;184:240–6.
21. Brouwers EP, Tiemens BG, Terluin B, Verhaak PF. Effectiveness
of an intervention to reduce sickness absence in patients with
emotional distress or minor mental disorders: a randomized
controlled effectiveness trial. Gen Hosp Psychiatry 2006;28:
223–9.
22. Kant IJ, Bu ¨ltmann U, Schro ¨er CAP, Beurskens AJHM, Van
Amelsvoort LPGM, Swaen GMH. An epidemiological approach
to study fatigue in the working population: The Maastricht Cohort
Study. Occup Environ Med 2003;60(Suppl 1):i32–i9.
23. Lund T, Labriola M, Villadsen E. Who is at risk for long-term
sickness absence? A prospective cohort study of Danish
employees. Work 2007;28:225–30.
24. Allebeck P, Mastekaasa A. Risk factors for sick leave—general
studies. Scand J Public Health 2004;32(Suppl 63):49–108.
86 J Occup Rehabil (2008) 18:79–86
123